PAULA STODDARD: Open Payments
NPI 1164007118 · HANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,654 in 270 payments from 18 companies in 2025. Trend: 2023 $1,205 · 2024 $3,270 · 2025 $16,654
Speaker / faculty: $12,900Food & beverage: $3,399Education: $180Travel & lodging: $175
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 87 | $13,995 |
| ABBVIE INC. | 55 | $675 |
| E.R. Squibb & Sons, L.L.C. | 57 | $533 |
| UCB, Inc. | 21 | $364 |
| GENZYME CORPORATION | 11 | $257 |
| Janssen Biotech, Inc. | 10 | $189 |
| Novartis Pharmaceuticals Corporation | 5 | $132 |
| Regeneron Healthcare Solutions, Inc. | 3 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Lilly USA, LLC | 3 | $71 |
Products named: NEMLUVIO, Sotyktu, DUPIXENT, RINVOQ, Bimzelx, SKYRIZI, TREMFYA, COSENTYX.
Industry payments across CA — which companies pay providers there.
